Loading...
At this year's annual meeting of the American Society of Clinical Oncology (ASCO 2018), held June 1–5 in Chicago, investigators discussed the latest findings in cancer research. The editors of NEJM Journal Watch Oncology and Hematology were on hand to report highlights of the conference. Associate Editor David H. Ilson, MD, PhD, reviewed key presentations on new gastrointestinal cancer treatments. All meeting abstracts can be viewed in the ASCO meeting library).
The key presentation from ASCO 2018 in gastrointestinal cancer was the PRODIGE 24/Unicancer CCTG trial (abstract LBA4001), an international, multicenter, randomized phase III study by Conroy and colleagues that compared adjuvant therapy with g…